James Goydos, M.D.
  • Home
  • About
    • About
    • Patents
    • Research
    • Patient Reviews
    • Camera Coverage
  • Blog
  • Contact
  • More
    • Home
    • About
      • About
      • Patents
      • Research
      • Patient Reviews
      • Camera Coverage
    • Blog
    • Contact

James Goydos, M.D.

  • Home
  • About
  • Blog
  • Contact

JAMES GOYDOS CLINICAL TRIALS & PATENTS

Innovative Cancer Patents by Dr. Goydos

During his experience as an M.D. and professor in the healthcare and academic domains, James Goydos has performed several clinical trials which have helped shape understanding and treatment of cancer, soft tissue tumors,  and melanoma. He has amassed over 80 authored or co-authored, abstracts, patents and publications  to his name. 


Goydos' work has directly translated into clinical trials for patients with melanoma. His collaborative inventions and research have revolutionized early skin cancer detection, treatment, and prevention both in his home state of New Jersey and across the international medical community. 

James Goydos (L) during tenure as Professor of Surgery, Rutgers Robert Wood Johnson Medical School

James Goydos (L) during tenure as Professor of Surgery, Rutgers Robert Wood Johnson Medical School

James Goydos et al. - Patents

Methods and compositions for treating melanoma

Methods and compositions for treating melanoma

Methods and compositions for treating melanoma

James Goydos et al patent,  ex. of drug trial. Fig 4D, Riluzole reduced growth of melanoma cells.

Patent Abstract: 


A method for inhibiting melanoma cell growth in a patient by administering to the patient a therapeutically effective amount of a glutamate release inhibitor, a GRM1 antagonist, or a combination thereof

Methods and compositions for treating cancer

Methods and compositions for treating melanoma

Methods and compositions for treating melanoma

James Goydos et al patent,  ex. of Trial of Riluzole for cancer. Fig 5B analysis on treated cells

Patent Abstract:


The present invention provides methods of treating cancer using 2-amino-6-trifluoromethoxybenzothiazole (riluzole). In one aspect, the present invention provides methods of reducing cancer cell growth. In another aspect, the present invention provides a method of inducing apoptosis in a cancer cell. In another aspect, the present invention provides a method of reducing the growth of a glutamate-releasing tumor.

Detection of mutations in nucleic acid sequences

Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation

Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation

James Goydos patent, detection of mutations to help diagnose and/or predict cancer predisposition.

Patent Abstract: 


The present invention is directed to a novel method for detecting a mutation in a target nucleic acid sequence. Such methods may be used to detect a mutation in a target nucleic acid sequence derived from a biological sample. Exemplary biological samples include, but are not limited to, samples derived from patients such as bodily fluids, tissues or cells. The methods of the invention are useful for detecting a mutation in a target nucleic acid sequence in such patient samples and thus, are of utility for diagnosing a disease in a patient and/or predicting a predisposition of a patient for a disease.

Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation

Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation

Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation

James Goydos et al patent, therapy after Phase 0 riluzole trial. Fig. 2 tumor volume / time

Patent Abstract:


Disclosed is a method of treating a tumor in a patient, comprising (a) administering riluzole in an amount effective to sensitize the tumor cells to ionizing radiation, and (b) irradiating the tumor cells with ionizing radiation in a dose effective to reduce tumor cell growth. The method can further comprise administering an effective amount of one or more additional therapeutic agents.


Copyright © 2021 James Goydos M.D. - All Rights Reserved.

  • Home
  • About
  • Patents
  • Patient Reviews
  • Camera Coverage
  • Blog
  • Contact

This website uses cookies & third-party links

We use cookies to analyze website traffic and optimize your website experience. By using this website, you accept the terms of service. When you consent to  our use of cookies, your data will be aggregated with all other user data. We use reasonable technical measures to protect user data under our control. 


This site links to third-party sites which are not maintained by James Goydos, M.D. We are not responsible for the content or privacy practices of any third-parties. We make no representation regarding the accuracy of content in such third-party sites. The inclusion of a third-party link does not imply endorsement. 


Accept